There is no clinical evidence that any transdermal or cosmetic GLP-1 patch can meaningfully affect blood sugar, appetite, or weight
Much of the metabolic research is still preclinical, but the mechanism makes it a useful tool for patients whose weight loss resistance is rooted in insulin resistance or mitochondrial inefficiency
You can also talk with your doctor or pharmacist
The disconnect between the population prevalence of obesity and care utilization is driven by a range of factors such as stigma and discrimination in healthcare settings, lack of educational and cultural training among physicians on how to address this issue with patients, and the cost of treatment
Reconstituted peptide stability guides these decisions
Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL